ARORA, MD, S.; SETNIK, PHD, B.; DRASS, MD, M.; HUDSON, MD, J. D.; CLEMMER, MS, R.; MEISNER, PHARMD, P.; PIXTON, MS, G. C.; GOLI, MD, V.; SOMMERVILLE, MD, K. W. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain. Journal of Opioid Management, [S. l.], v. 10, n. 6, p. 423–436, 2014. DOI: 10.5055/jom.2014.0239. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/120. Acesso em: 29 apr. 2024.